Latest updates for Acquired Hemophilia

Fresh curated links around acquired hemophilia are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Real-world study backs safety of Hemlibra for acquired hemophilia A
  • Confident protection from hemophilia A
  • Data show hemophilia bleeds can be successfully treated while on Hympavzi

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hemophilianewstoday.com /1 week ago

Real-world study backs safety of Hemlibra for acquired hemophilia A

Hemlibra (emicizumab) alongside immunosuppressive therapy appears safe for use in acquired hemophilia A (AHA), according to initial results of a real-world study in Japan, the only...

Read source
hemophilianewstoday.com /1 month ago

Confident protection from hemophilia A

The post Confident protection from hemophilia A appeared first on Hemophilia News Today.

Read source
hemophilianewstoday.com /1 week ago

Data show hemophilia bleeds can be successfully treated while on Hympavzi

In the large clinical trial that supported the 2024 approval of Hympavzi (marstacimab) for adults and children with hemophilia, use of the prophylactic injection therapy was found...

Read source
jpeds.com /2 weeks ago

Acute Hemorrhagic Edema of Infancy Beyond Infancy

A 6-year-old girl presented to the emergency department with purpuric lesions, arthralgia, and low-grade fever, one week after diphtheria-tetanus-acellular pertussis-inactivated po...

Read source
hemophilianewstoday.com /1 month ago

Most men with hem A bleed-free 5 years after 1 Roctavian dose

A single dose of the gene therapy Roctavian (valoctocogene roxaparvovec-rvox) continues to prevent bleeds and the need for preventive treatment (prophylaxis) for up to five years i...

Read source
hemophilianewstoday.com /2 weeks ago

Hympavzi now approved for more hemophilia patients in Europe

The European Commission has approved Hympavzi (marstacimab) to treat certain people with hemophilia A or hemophilia B who have inhibitors, the therapy’s maker, Pfizer, announced. H...

Read source
hemophilianewstoday.com /1 month ago

Single infusion of Roctavian linked to fewer bleeds in hemophilia A

Roctavian (valoctocogene roxaparvovec-rvox) was associated with fewer bleeding episodes and less need for preventive treatment, or prophylaxis, in most adult men with severe hemoph...

Read source
hemophilianewstoday.com /1 month ago

FX activator may help with bleeding control in hemophilia A and B: Trials

Bemiltenase alfa, an experimental factor X (FX) activator, helped with on-demand bleeding control for people with hemophilia A and B who had developed inhibitors against standard f...

Read source
hemophilianewstoday.com /1 week ago

Prophylaxis and on-demand treatment for hemophilia: How doctors decide

After a hemophilia diagnosis, people typically work with their care team to develop a tailored treatment plan. This will likely involve considering both preventive (prophylactic) a...

Read source
hemophilianewstoday.com /1 month ago

Protein marker may detect early joint damage in hemophilia A

Measuring levels of YKL-40 — a protein associated with inflammation and tissue remodeling — may help detect hemophilic arthropathy, the joint damage caused by repeated bleeding, in...

Read source
hemophilianewstoday.com /4 days ago

Hemophilia patients still face unmet health needs despite treatment

People with hemophilia still experience significant unmet health needs despite receiving preventive treatment, according to an international study. “Despite current treatment, many...

Read source
hemophilianewstoday.com /4 weeks ago

Many women with hemophilia-related mutations lack access to medical care

Many women carrying hemophilia-related mutations are not receiving the medical attention they need, according to a large-scale multinational study. Despite being treated in establi...

Read source
hemophilianewstoday.com /1 day ago

WHO members adopt global resolution on bleeding disorder care

At the World Health Assembly (WHA), member states of the World Health Organization (WHO) unanimously adopted a resolution on Global Action to Advance Health Equity for People with...

Read source
hemophilianewstoday.com /2 days ago

Hemophilia bleed or pain? How to tell when pain needs attention

When you have hemophilia, any new aches or pains can be a cause for concern. Because bleeding can happen in joints, muscles, and soft tissues, changes such as pain, swelling, or ti...

Read source
hemophilianewstoday.com /2 days ago

Finding strength and sisterhood through hemophilia advocacy

Tracye Hamler shares how her hemophilia diagnosis inspired her to create Free Bleeders and advocate for women with bleeding disorders through community, education, and visibility....

Read source
hemophilianewstoday.com /1 month ago

Hemlibra outperforms ITI in controlling bleeding in hemophilia A children

Preventive treatment with Hemlibra (emicizumab) is associated with better bleeding control and lower medication costs compared with immune tolerance induction, or ITI, among childr...

Read source
hemophilianewstoday.com /4 days ago

What to do during a bleeding emergency with hemophilia

When you or someone you love has hemophilia, even what seems like a minor bleed can quickly become serious. Knowing how to recognize a bleeding emergency and what steps to take can...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Acquired Hemophilia

hemophilianewstoday.com

Recent coverage from public sources
Public source

jpeds.com

Recent coverage from public sources
Public source